reviewTop 1% cited

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

The American Journal of Gastroenterology · 2015 · Vol. 110(6) · pp. 802–819

Mahmoud Mosli(Robarts Clinical Trials)Guangyong Zou(Robarts Clinical Trials)Sushil Kumar Garg(University of Minnesota)Sean Feagan✉(Robarts Clinical Trials)John K MacDonald(Robarts Clinical Trials)Nilesh Chande(Western University)William J. Sandborn(Robarts Clinical Trials)Brian G. Feagan✉(Robarts Clinical Trials)

View via DOI Publisher page

Abstract

Although CRP, FC, and SL are useful biomarkers, their value in managing individual patients must be considered in specific clinical contexts.

Inflammatory Bowel Disease Microscopic Colitis Infant Nutrition and HealthMedicineCalprotectinInternal medicineGastroenterologyInflammatory bowel diseaseUlcerative colitisGold standard (test)Confidence intervalC-reactive proteinFaecal calprotectin

MeSH terms

C-Reactive ProteinColitis, UlcerativeCrohn DiseaseFecesHumansLactoferrinSensitivity and SpecificityBiomarkersEndoscopy, GastrointestinalLeukocyte L1 Antigen Complex

Citations

662

FWCI

31.37

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

ACG Clinical Guideline: Ulcerative Colitis in Adults